Eisai Archives -

FDA clears Eisai’s insomnia drug Dayvigo

https://pharmaphorum.com/news/fda-clears-eisais-insomnia-drug-dayvigo/

Surprise! Biogen says Alzheimer’s drug works after all and will be filed

https://pharmaphorum.com/news/surprise-biogen-says-alzheimers-drug-works-after-all-and-will-be-filed/

Merck, Eisai get triple approvals for Keytruda/Lenvima combination

https://pharmaphorum.com/news/merck-eisai-get-triple-approvals-for-keytruda-lenvima-combination/

Last BACE bombs: Eisai, Biogen give up on elenbecestat

https://pharmaphorum.com/news/last-bace-bombs-eisai-biogen-give-up-on-elenbecestat/

Biogen, Eisai hit hard as Alzheimer’s drug is abandoned

https://pharmaphorum.com/news/biogen-eisai-hit-hard-as-alzheimers-drug-is-abandoned/

Eisai, Takeda and GARDP hunt for new antibiotics

https://pharmaphorum.com/news/eisai-takeda-and-gardp-hunt-for-new-antibiotics/

Taking on the challenge of childhood epilepsy

https://pharmaphorum.com/r-d/views-analysis-r-d/taking-challenge-childhood-epilepsy/

Eisai/Merck & Co’s Lenvima approved in EU for first line liver cancer

https://pharmaphorum.com/news/eisai-merck-cos-lenvima-approved-in-eu-for-first-line-liver-cancer/

Biogen and Eisai Alzheimer’s drug excites doctors, but not investors

https://pharmaphorum.com/news/biogen-and-eisai-alzheimers-drug-excites-doctors-but-not-investors/

Search